[English] 日本語
Yorodumi
- PDB-8ymb: The crystal structure of SHD931 in complex with Brd4-BD2 and VCB -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 8ymb
TitleThe crystal structure of SHD931 in complex with Brd4-BD2 and VCB
Components
  • Bromodomain-containing protein 4
  • Elongin-B
  • Elongin-C
  • von Hippel-Lindau disease tumor suppressor
KeywordsLIGASE / Complex / Protac / Macrocyclic
Function / homology
Function and homology information


regulation of cellular response to hypoxia / RHOBTB3 ATPase cycle / negative regulation of receptor signaling pathway via JAK-STAT / target-directed miRNA degradation / transcription elongation factor activity / VCB complex / elongin complex / Replication of the SARS-CoV-1 genome / Cul5-RING ubiquitin ligase complex / intracellular membraneless organelle ...regulation of cellular response to hypoxia / RHOBTB3 ATPase cycle / negative regulation of receptor signaling pathway via JAK-STAT / target-directed miRNA degradation / transcription elongation factor activity / VCB complex / elongin complex / Replication of the SARS-CoV-1 genome / Cul5-RING ubiquitin ligase complex / intracellular membraneless organelle / Cul2-RING ubiquitin ligase complex / SUMOylation of ubiquitinylation proteins / negative regulation of transcription elongation by RNA polymerase II / RNA polymerase II C-terminal domain binding / P-TEFb complex binding / Pausing and recovery of Tat-mediated HIV elongation / Tat-mediated HIV elongation arrest and recovery / negative regulation of DNA damage checkpoint / HIV elongation arrest and recovery / Pausing and recovery of HIV elongation / negative regulation by host of viral transcription / Tat-mediated elongation of the HIV-1 transcript / ubiquitin-like ligase-substrate adaptor activity / Formation of HIV-1 elongation complex containing HIV-1 Tat / negative regulation of signal transduction / positive regulation of T-helper 17 cell lineage commitment / Formation of HIV elongation complex in the absence of HIV Tat / RNA Polymerase II Transcription Elongation / Formation of RNA Pol II elongation complex / negative regulation of TORC1 signaling / protein serine/threonine kinase binding / positive regulation of G2/M transition of mitotic cell cycle / RNA Polymerase II Pre-transcription Events / RNA polymerase II CTD heptapeptide repeat kinase activity / negative regulation of autophagy / condensed nuclear chromosome / transcription corepressor binding / histone reader activity / : / positive regulation of transcription elongation by RNA polymerase II / positive regulation of cell differentiation / transcription coregulator activity / TP53 Regulates Transcription of DNA Repair Genes / transcription initiation at RNA polymerase II promoter / transcription elongation by RNA polymerase II / Vif-mediated degradation of APOBEC3G / Inactivation of CSF3 (G-CSF) signaling / cell morphogenesis / Evasion by RSV of host interferon responses / Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha / Regulation of expression of SLITs and ROBOs / ubiquitin-protein transferase activity / transcription corepressor activity / p53 binding / Antigen processing: Ubiquitination & Proteasome degradation / positive regulation of proteasomal ubiquitin-dependent protein catabolic process / Neddylation / chromosome / microtubule cytoskeleton / regulation of gene expression / Replication of the SARS-CoV-2 genome / protein-containing complex assembly / ubiquitin-dependent protein catabolic process / regulation of inflammatory response / protein-macromolecule adaptor activity / DNA-binding transcription factor binding / molecular adaptor activity / cellular response to hypoxia / histone binding / amyloid fibril formation / proteasome-mediated ubiquitin-dependent protein catabolic process / Potential therapeutics for SARS / positive regulation of canonical NF-kappaB signal transduction / transcription coactivator activity / transcription cis-regulatory region binding / protein stabilization / protein ubiquitination / cilium / chromatin remodeling / negative regulation of cell population proliferation / negative regulation of gene expression / protein serine/threonine kinase activity / ubiquitin protein ligase binding / DNA damage response / chromatin binding / regulation of DNA-templated transcription / regulation of transcription by RNA polymerase II / negative regulation of apoptotic process / chromatin / positive regulation of DNA-templated transcription / enzyme binding / negative regulation of transcription by RNA polymerase II / endoplasmic reticulum / positive regulation of transcription by RNA polymerase II / mitochondrion / proteolysis / nucleoplasm / nucleus / plasma membrane / cytosol
Similarity search - Function
von Hippel-Lindau disease tumour suppressor, beta/alpha domain / von Hippel-Lindau disease tumour suppressor, alpha domain / von Hippel-Lindau disease tumour suppressor, beta domain / VHL superfamily / von Hippel-Lindau disease tumour suppressor, alpha domain superfamily / von Hippel-Lindau disease tumour suppressor, beta domain superfamily / VHL beta domain / VHL box domain / Elongin-C / Elongin B ...von Hippel-Lindau disease tumour suppressor, beta/alpha domain / von Hippel-Lindau disease tumour suppressor, alpha domain / von Hippel-Lindau disease tumour suppressor, beta domain / VHL superfamily / von Hippel-Lindau disease tumour suppressor, alpha domain superfamily / von Hippel-Lindau disease tumour suppressor, beta domain superfamily / VHL beta domain / VHL box domain / Elongin-C / Elongin B / S-phase kinase-associated protein 1-like / SKP1 component, POZ domain / Skp1 family, tetramerisation domain / Found in Skp1 protein family / Bromodomain protein 4, C-terminal / C-terminal domain of bromodomain protein 4 / Brdt, bromodomain, repeat I / Brdt, bromodomain, repeat II / NET domain superfamily / NET domain profile. / : / NET domain / Bromodomain extra-terminal - transcription regulation / SKP1/BTB/POZ domain superfamily / Bromodomain, conserved site / Bromodomain signature. / Bromodomain / Bromodomain profile. / bromo domain / Bromodomain / Bromodomain-like superfamily / Ubiquitin family / Ubiquitin homologues / Ubiquitin domain profile. / Ubiquitin-like domain / Ubiquitin-like domain superfamily
Similarity search - Domain/homology
: / Bromodomain-containing protein 4 / von Hippel-Lindau disease tumor suppressor / Elongin-C / Elongin-B
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.95 Å
AuthorsHuang, W.X. / Chen, Y.H. / Li, C.G. / Ding, K.
Funding support China, 1items
OrganizationGrant numberCountry
National Natural Science Foundation of China (NSFC)32071446 China
CitationJournal: Jacs Au / Year: 2024
Title: Structure-Based Design of "Head-to-Tail" Macrocyclic PROTACs.
Authors: Li, C. / Chen, Y. / Huang, W. / Qiu, Y. / Huang, S. / Zhou, Y. / Zhou, F. / Xu, J. / Ren, X. / Zhang, J. / Wang, Z. / Ding, M. / Ding, K.
History
DepositionMar 8, 2024Deposition site: PDBJ / Processing site: PDBJ
Revision 1.0Feb 12, 2025Provider: repository / Type: Initial release

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Bromodomain-containing protein 4
B: Elongin-B
C: Elongin-C
D: von Hippel-Lindau disease tumor suppressor
F: Bromodomain-containing protein 4
G: Elongin-B
H: Elongin-C
I: von Hippel-Lindau disease tumor suppressor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)117,93818
Polymers115,6738
Non-polymers2,26410
Water23413
1
A: Bromodomain-containing protein 4
B: Elongin-B
C: Elongin-C
D: von Hippel-Lindau disease tumor suppressor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)59,00410
Polymers57,8374
Non-polymers1,1686
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
2
F: Bromodomain-containing protein 4
G: Elongin-B
H: Elongin-C
I: von Hippel-Lindau disease tumor suppressor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)58,9338
Polymers57,8374
Non-polymers1,0974
Water724
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)84.061, 84.388, 382.717
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number20
Space group name H-MC2221
Space group name HallC2c2
Symmetry operation#1: x,y,z
#2: x,-y,-z
#3: -x,y,-z+1/2
#4: -x,-y,z+1/2
#5: x+1/2,y+1/2,z
#6: x+1/2,-y+1/2,-z
#7: -x+1/2,y+1/2,-z+1/2
#8: -x+1/2,-y+1/2,z+1/2
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-IDDetails
d_1ens_1(chain "A" and ((resid 350 and (name N or name...
d_2ens_1(chain "F" and (resid 350 through 422 or (resid 423...
d_1ens_2(chain "B" and (resid 1 through 45 or (resid 46...
d_2ens_2(chain "G" and (resid 1 through 35 or (resid 36...
d_1ens_3(chain "C" and (resid 16 through 47 or resid 58...
d_2ens_3(chain "H" and (resid 16 through 88 or (resid 89...
d_1ens_4(chain "D" and (resid 62 through 63 or (resid 64...
d_2ens_4(chain "I" and (resid 62 through 72 or (resid 73...

NCS domain segments:
Dom-IDComponent-IDEns-IDBeg auth comp-IDBeg label comp-IDEnd auth comp-IDEnd label comp-IDAuth asym-IDLabel asym-IDAuth seq-IDLabel seq-ID
d_11ens_1VALVALMETMETAA350 - 45718 - 125
d_21ens_1VALVALMETMETFE350 - 45718 - 125
d_11ens_2METMETLYSLYSBB1 - 1045 - 108
d_21ens_2METMETLYSLYSGF1 - 1045 - 108
d_11ens_3SERSERSERSERCC16 - 472 - 33
d_12ens_3ASNASNCYSCYSCC58 - 11244 - 98
d_21ens_3SERSERCYSCYSHG16 - 1122 - 98
d_11ens_4VALVALLEULEUDD62 - 14010 - 88
d_12ens_4PROPROHISHISDD146 - 20894 - 156
d_21ens_4VALVALHISHISIH62 - 20810 - 156

NCS ensembles :
ID
ens_1
ens_2
ens_3
ens_4

NCS oper:
IDCodeMatrixVector
1given(-0.00252555373573, 0.999993176957, 0.00269585200994), (0.999995557639, 0.00252980928767, -0.00157631440589), (-0.00158312364208, 0.00269185896725, -0.999995123796)-42.1335671693, -0.0302800184562, -95.7346053271
2given(0.00366211261758, 0.999992994474, 0.000774554506628), (0.999990946496, -0.00366378139712, 0.00216417018481), (0.00216699282205, 0.000766622059255, -0.999997358213)-41.9935287869, 0.114563630527, -95.7035069375
3given(0.00123385435621, 0.999999228841, -0.000141140507636), (0.999999237236, -0.00123384644543, 5.61223111655E-5), (5.59481221726E-5, -0.000141209646737, -0.999999988465)-42.0330484708, 0.00790163664996, -95.6765298761
4given(-0.00686280935314, 0.999972058152, 0.00296391009389), (0.999975893617, 0.00686590387289, -0.00103515664171), (-0.00105547763931, 0.00295673456206, -0.999995071832)-41.9817522642, -0.214614739102, -95.7409939395

-
Components

-
Protein , 4 types, 8 molecules AFBGCHDI

#1: Protein Bromodomain-containing protein 4 / Protein HUNK1


Mass: 14842.058 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: BRD4, HUNK1 / Production host: Escherichia coli BL21(DE3) (bacteria) / References: UniProt: O60885
#2: Protein Elongin-B / EloB / Elongin 18 kDa subunit / RNA polymerase II transcription factor SIII subunit B / SIII p18 / ...EloB / Elongin 18 kDa subunit / RNA polymerase II transcription factor SIII subunit B / SIII p18 / Transcription elongation factor B polypeptide 2


Mass: 13436.042 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: ELOB, TCEB2 / Production host: Escherichia coli BL21(DE3) (bacteria) / References: UniProt: Q15370
#3: Protein Elongin-C / EloC / Elongin 15 kDa subunit / RNA polymerase II transcription factor SIII subunit C / SIII p15 / ...EloC / Elongin 15 kDa subunit / RNA polymerase II transcription factor SIII subunit C / SIII p15 / Transcription elongation factor B polypeptide 1


Mass: 10987.550 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: ELOC, TCEB1 / Production host: Escherichia coli BL21(DE3) (bacteria) / References: UniProt: Q15369
#4: Protein von Hippel-Lindau disease tumor suppressor / Protein G7 / pVHL


Mass: 18571.096 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: VHL / Production host: Escherichia coli BL21(DE3) (bacteria) / References: UniProt: P40337

-
Non-polymers , 3 types, 23 molecules

#5: Chemical
ChemComp-CL / CHLORIDE ION


Mass: 35.453 Da / Num. of mol.: 8
Source method: isolated from a genetically manipulated source
Formula: Cl
#6: Chemical ChemComp-A1LY0 / SHD931


Mass: 990.286 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Formula: C53H67N9O6S2 / Feature type: SUBJECT OF INVESTIGATION
#7: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 13 / Source method: isolated from a natural source / Formula: H2O

-
Details

Has ligand of interestY
Has protein modificationN

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.85 Å3/Da / Density % sol: 56.81 %
Crystal growTemperature: 291 K / Method: vapor diffusion, sitting drop / pH: 8.5
Details: 1500 mM Ammonium sulfate, 100 mM Tris base/ Hydrochloric acid, pH 8.5, 12% (v/v) Glycerol

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: SSRF / Beamline: BL10U2 / Wavelength: 0.97918 Å
DetectorType: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Jan 22, 2024
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.97918 Å / Relative weight: 1
ReflectionResolution: 2.95→47.84 Å / Num. obs: 29155 / % possible obs: 99.41 % / Redundancy: 5.2 % / Biso Wilson estimate: 72.98 Å2 / CC1/2: 0.994 / Rmerge(I) obs: 0.16 / Net I/σ(I): 10.55
Reflection shellResolution: 2.95→3.055 Å / Rmerge(I) obs: 1.085 / Mean I/σ(I) obs: 1.85 / Num. unique obs: 2837 / CC1/2: 0.615

-
Processing

Software
NameVersionClassification
PHENIX1.20.1_4487refinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 5T35
Resolution: 2.95→47.84 Å / SU ML: 0.3797 / Cross valid method: FREE R-VALUE / σ(F): 1.34 / Phase error: 29.2758
Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2
RfactorNum. reflection% reflection
Rfree0.2702 2004 6.89 %
Rwork0.2396 27092 -
obs0.2417 29096 99.44 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso mean: 76.51 Å2
Refinement stepCycle: LAST / Resolution: 2.95→47.84 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms6992 0 148 13 7153
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.00427311
X-RAY DIFFRACTIONf_angle_d0.62359937
X-RAY DIFFRACTIONf_chiral_restr0.04521103
X-RAY DIFFRACTIONf_plane_restr0.00431276
X-RAY DIFFRACTIONf_dihedral_angle_d12.50262679
Refine LS restraints NCS
Ens-IDDom-IDAsym-IDAuth asym-IDRefine-IDTypeRms dev position (Å)
ens_1d_2AAX-RAY DIFFRACTIONTorsion NCS0.49225335941
ens_2d_2BBX-RAY DIFFRACTIONTorsion NCS0.714434705039
ens_3d_2CCX-RAY DIFFRACTIONTorsion NCS0.527187096021
ens_4d_2DDX-RAY DIFFRACTIONTorsion NCS0.56735773628
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
2.95-3.020.35531370.31841931X-RAY DIFFRACTION100
3.02-3.110.34181410.30551908X-RAY DIFFRACTION99.95
3.11-3.20.32351430.29921888X-RAY DIFFRACTION99.85
3.2-3.30.37791440.28771951X-RAY DIFFRACTION100
3.3-3.420.29371360.27231894X-RAY DIFFRACTION99.75
3.42-3.550.3381420.29281933X-RAY DIFFRACTION99.95
3.55-3.720.29341450.25471940X-RAY DIFFRACTION99.76
3.72-3.910.28421420.24321920X-RAY DIFFRACTION99.85
3.91-4.160.29541410.2221911X-RAY DIFFRACTION99.52
4.16-4.480.21271430.21611936X-RAY DIFFRACTION99.62
4.48-4.930.25341480.20991961X-RAY DIFFRACTION99.43
4.93-5.640.27621420.23231939X-RAY DIFFRACTION99.52
5.64-7.10.30561470.25221993X-RAY DIFFRACTION99.67
7.1-47.840.19511530.2021987X-RAY DIFFRACTION95.54
Refinement TLS params.Method: refined / Origin x: -10.2537043538 Å / Origin y: 10.6872948703 Å / Origin z: -47.7150809948 Å
111213212223313233
T0.509969049558 Å20.0888672021095 Å20.073175283152 Å2-0.448404544007 Å2-0.0677644322965 Å2--0.727715828072 Å2
L0.30952582773 °20.127622368575 °2-0.0915142650385 °2-0.328222678112 °20.0145774628701 °2--0.272147705367 °2
S-0.00493770802346 Å °0.0337744605157 Å °0.0614935062908 Å °0.00492657060071 Å °0.0512676249717 Å °-0.0487676400879 Å °0.0178161374061 Å °0.0159048107842 Å °-0.0559235903882 Å °
Refinement TLS groupSelection details: all

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more